Kythera Biophrm (KYTH) Posts Q1 Loss of $3.18/Share

Kythera Biophrm (NASDAQ: KYTH) reported Q1 EPS of ($3.18), $2.51 worse than the analyst estimate of ($0.67).

For earnings history and earnings-related data on Kythera Biophrm (KYTH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Vivos Therapeutics posts 35% revenue gain but widens net loss
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c